N. K. Venkataramana

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury—outcomes at 6 months

Phil Edwards, Miguel Arango, Laura Balica et al. · The Lancet · 2005 · 840 citations

Traumatic Brain Injury, Medicine, Head Injury—outcomes +6

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Ulrich Bogdahn, Peter Hau, Günther Stockhammer et al. · Neuro-Oncology · 2010 · 424 citations · Full text

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease

N. K. Venkataramana, Satish K.V. Kumar, Sudheer Balaraju et al. · Translational research · 2009 · 386 citations

Regenerative Medicine, Open-labeled Study, Cell Therapy +10

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

Rakhi Pal, N. K. Venkataramana, Abhilash Bansal et al. · Cytotherapy · 2009 · 229 citations

Tissue Engineering, Regenerative Medicine, Spinal Cord Injury +14

Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson’s Disease: A Pilot Clinical Study

N. K. Venkataramana, Rakhi Pal, Shailesh A V Rao et al. · Stem Cells International · 2012 · 94 citations · Full text